옵션 체인은 다양한 행사가격과 만기일에 대한 Ryan Specialty Hldgs의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Ryan Specialty Hldgs에 대한 시장 심리를 평가합니다..

Ryan Specialty Hldgs (NYSE:RYAN) 주식, 옵션 체인

RYAN SPECIALTY HOLDINGS INC

Ryan Specialty Hldgs

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Minnetonka,,Mn - usa,-,August,13,,2015:,Unitedhealth,Group,Headquarters,Building.

Earnings

Equities

Large Cap

News

Movers

ERIE

RYAN

TMUS

지난주 최악의 실적을 기록한 대형주는 다음과 같다. 피서브, 노스롭, 이리 인뎀니티, T-모바일, 왓스코, 골드 필즈, 에이온, 앵글로골드 아샨티, 라이언 스페셜티, 타일러 테크놀로지스, 킴벌리 클라크, 유나이티드헬스

유나이티드헬스·노스롭·T-모바일 등 지난주 급락한 대형주 12종목 (4월 21~25일)

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Holdings Inc

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Holdings PLC

RYANAIR HLDGS PLC ORD NEW by Ryanair Holdings Plc

Thumzup Recently Added Stripe's New Crypto Payment Option for Advertisers
Company's Utilization of Bitcoin and Crypto Aligns with White House Plans to Make the USA the Crypto Capital of the World
LOS ANGELES, May 19, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4430769-1&amp;h=3351642801&amp;u=https%3A%2F%2Fwww.thumzupmedia.com%2F&amp;a=Thumzup">Thumzup</a><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4430769-1&amp;h=3320532072&amp;u=https%3A%2F%2Fwww.thumzupmedia.com%2F&amp;a=Media+Corporation">Media Corporation</a> ("Thumzup" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) today announced it has expanded its cryptocurrency capabilities by enabling Stripe's "Pay with Crypto" to accept stablecoins like USDC as payments for Thumzup advertising campaigns.
This important development comes as Thumzup is moving to accelerate its Bitcoin acquisition strategy, which, as previously disclosed, permits the Company to hold up to 90% of its liquid assets in BTC. As of May 19, 2025, Thumzup currently holds 19.106 BTC, with a market value of approximately $2.0 million. Thumzup currently utilizes Coinbase Prime as its custodian and prime broker.

TZUP

Thumzup Announces It Recently Added Stripe's New Crypto Payment Option For Advertisers; As of May 19, 2025, Thumzup Currently Holds 19.106 BTC, With A Market Value Of ~$2M

D. Boral Capital analyst Jason Kolbert downgrades Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) from Buy to Hold.

Downgrades

Analyst Ratings

IMNN

D. Boral Capital Downgrades Imunon to Hold

<ul class="wp-block-list">
<li>American consumer debt hit $18.2 trillion in the Q1 2025, according to the Federal Reserve Bank of New York</li>
<li>While credit card and auto loan balances are both declining, student loan debt and mortgage balances have increased</li>
<li>Student loan debt was also identified as the primary driver behind delinquent debt, which increased 4.3% over the last quarter</li>
</ul>
Americans' consumer debt hit an all-time high in the Q1 2025, according to the Federal Reserve Bank of New York's "Quarterly Report on Household Debt and Credit." The <a href="https://www.newyorkfed.org/microeconomics/hhdc">report</a>, which was released Tuesday, says that household debt is at $18.2 trillion, up $167 billion since Q4 2024.
In two categories, credit card balances and auto loan balances, Americans are actually lowering their debt loads. According to the report, credit card balances fell by $29 billion and auto loan balances decreased by $13 billion.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
However, Ted Rossman, a senior industry analyst at Bankrate, told <a href="https://www.cnn.com/2025/05/13/business/household-debt-report-credit-cards-student-loans">CNN</a>, "Don't be fooled by the modest decrease[s]. Credit card balanc﻿es and interest rates remain near record highs." According to Rossman, credit card balances are 54% higher than they were four years ago, and auto loan balances have gone up by 19% over the same period.&nbsp;
The long-term upward trend of credit balances is unsurprising. The NY Fed's data does not account for inflation, or factor in things like population growth, the rise of e-commerce, or the strength of consumer spending.
What is surprising to analysts and experts, however, is the drop in auto loan balances. These fell for the first time since 2011, according to CNN.
Matt Schultz, chief consumer finance analyst at LendingTree, explained the phenomenon to CNN. "I think it's a combination of people not buying [cars] because of high interest rates and high prices and also just the amount of uncertainty that we have had in the economy the last few months," he said. "That may have spurred people to hunker down a little bit."
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Two other categories of consumer debt, student loan balances and mortgage balances, saw an increase in debt loads. Student loan balances grew by $16 billion to $1.63 trillion, and mortgage balances went up by $199 billion to $12.8 trillion. Aggregate delinquency rates also rose this quarter, with 4.3% of debt now in some stage of delinquency.&nbsp;
Student loans are one of the chief drivers of delinquent debt. After a 3.5 year pause on payments and the end of President Joe Biden's one-year "on-ramp" extension, student loans payments have resumed in full as of Sept. 30, and missed payments now affect credit reports.&nbsp;
According to the NY Fed's new report, student loan delinquencies have jumped from 1% to 7.74% in the Q1. While half of the newly delinquent borrowers already had subprime credit scores, 2.4 million others had scores of above 620 and saw them drop more than 140 points.&nbsp;
Charlie Wise, head of global research and consulting at TransUnion, told CNN this could have severe impacts on the average borrower. "Consumers who previously would have had very good access to most credit products, including mortgages, now will have a much more difficult time getting credit — if at all," he said.
Read Next:
<ul class="wp-block-list">
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
Image: Shutterstock

Personal Finance

Americans' Consumer Debt Hits All-Time High of $18.2 Trillion, Experts Say Some Borrowers 'Will Have A Much More Difficult Time Getting Credit' Going Forward

Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) has outperformed the market over the past 5 years by 12.16% on an annualized basis producing an average annual return of 27.07%. Currently, Johnson Controls Intl has a market capitalization of $63.64 billion. 
Buying $1000 In JCI: If an investor had bought $1000 of JCI stock 5 years ago, it would be worth $3,327.10 today based on a price of $96.41 for JCI at the time of writing.
<h3>Johnson Controls Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747667712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Johnson Controls Intl 5 Years Ago Would Be Worth This Much Today

PARA

Reuters Reports Wendy McMahon To Step Down As President And CEO Of CBS News And Stations And CBS Media Ventures

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) with a Hold and lowers the price target from $1.8 to $1.08.

Price Target

AKYA

Canaccord Genuity Maintains Hold on Akoya Biosciences, Lowers Price Target to $1.08

As Moody's strips the U.S. of its last AAA credit rating, financial markets and currency analysts are weighing whether the dollar's role as the world's primary reserve <a href="https://www.benzinga.com/25/05/45492889/americas-credit-strength-just-got-cut-again-should-you-panic">currency could slowly erode. </a>
Analysts across major institutions agree that Treasuries remain indispensable in global finance, and no mechanical turmoil is expected in the near term.
Yet, the downgrade's timing and symbolism—arriving amid growing fiscal deficits, political uncertainty and weakening sentiment—have amplified calls for greater diversification from dollar-denominated investments for foreign investors.
<h3 class="wp-block-heading">Dollar&#8217;s Dominance Isn't Over, But It's Under Pressure</h3>
"The link between U.S. sovereign risk, Treasuries, and the dollar is one of capital flight," said Chris Turner, analyst at ING Group. 
"Are global investors shifting their portfolios away from the U.S.?" 
He highlighted that March data from the U.S. Treasury's International Capital report showed foreign buyers added $26 billion in Treasuries, though China trimmed its holdings by $19 billion. 
Turner said upcoming TIC data for April, due mid-June, will be key to determining any real trend.
<h3 class="wp-block-heading">Downgrade Could Spark Market Volatility</h3>
According to Alejandro Cuadrado, forex strategist at BBVA, Moody's downgrade—though symbolic—arrives at a vulnerable time.
"It may act as a psychological catalyst," he said. Unlike S&amp;P's 2011 or Fitch's 2023 downgrades, this one coincides with bearish sentiment in Treasuries and rising global fiscal concern.
Cuadrado said the structural use of Treasuries in collateral systems, reserve portfolios and liquidity management remains unchanged. 
Still, "in this macro environment, the downgrade could amplify market jitters and FX volatility," he said, potentially weakening the dollar's ability to rebound after a three-month slide.
"The downgrade highlights long-term risks, including debt sustainability, which could further erode the dollar's haven appeal," George Vessey, lead macro strategist at Convera, said.
<h3 class="wp-block-heading">Time to Start Reducing Dollar Exposure?</h3>
According to UBS, the recent consolidation in the dollar following earlier weakness offers a strategic moment for reallocation.
"We believe that this provides an opportunity for investors with excess USD cash, or international investors with unhedged exposure to U.S. assets, to reduce their exposure to the U.S. dollar."
Over the long term, UBS sees further structural risks. "The trend of international diversification could lead to further dollar weakness, particularly if the Federal Reserve begins to play a more active role intervening in bond markets amid high fiscal deficits."
<h3 class="wp-block-heading">Not A Collapse For Now, Yet Caution Is Warranted</h3>
The Dollar Index (DXY) – which is tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – fell 0.8% on Monday, erasing gains from last week on the back of a U.S.-China trade truce.
Capital flight hasn't hit the data yet, but concerns about U.S. debt and policy are starting to grow worldwide.
For the time being, the dollar remains the anchor of global trade and finance—but the psychological buffer it once enjoyed is showing cracks, and that shift may matter more than a credit downgrade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/bonds/25/05/45396490/peter-schiff-says-trade-truce-aside-the-world-is-losing-confidence-in-dollar-and-in-us-ability-to-put-fiscal-house-in-order">Peter Schiff Says Trade Truce Aside, The World Is &#8216;Losing Confidence&#8217; In Dollar And In US Ability To Put &#8216;Fiscal House In Order&#8217;</a> </li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Currency ETFs

Forex

Econ #s

ETFs

PowerShares DB US Dollar Index Bullish Fund

Is The Dollar's Global Reserve Role At Risk After Moody's Downgrade?

Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), a cloud-based data storage provider, will report its first-quarter results <a href="https://www.benzinga.com/topic/cloud">on Wednesday, May 21</a>.
According to Goldman Sachs, Snowflake's fundamentals are strengthening, and the company is likely to report strong quarterly results and guidance.
The Snowflake Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58c6ab8db85e9300015f1ae0/kash-rangan">Analyst Kash Rangan</a> maintained a Buy rating and price target of $205.
The Snowflake Thesis: The Bozeman, Montana-based company is likely to report Product Revenue growth of 21% and non-GAAP operating margins of 5%, in-line with consensus estimates, Rangan said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
There is potential for "beat and flow-through, supported by Datadog and Hyperscalers seeing stable consumption trends in April," he added.
Core Data Engineering is scaling quickly, driven by Snowpark and Dynamic Tables, while Cortex could benefit from AI momentum into the back half of the year, the analyst stated. Recent partnerships with Microsoft/OpenAI and Anthropic help Snowflake increase credibility and reach, he further stated.
"We believe Snowflake's strengthening fundamentals, new product velocity under CEO Ramaswamy's strategic leadership, a more efficient GTM motion, and recent tariff relief serve as net-positives for underwriting 2H growth acceleration," Rangan wrote.
Price Action: Shares of Snowflake had declined by 0.45% to $182.34 at the time of publication on Monday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">Snowflake (SNOW) Stock Gains Amid Tech Rally, CPI Miss: What&#8217;s Going On?</a></li>
</ul>
Image: Shutterstock

Previews

Reiteration

Tech

SNOW

Snowflake Eyes Q1 Momentum As AI Partnerships Stack Up: Goldman Sachs

LHSW

Lianhe Sowell International Shares Resume Trade

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) <a href="https://www.benzinga.com/money/how-to-buy-solana#:~:text=Make%20Your%20Purchase&amp;text=To%20complete%20the%20transaction%2C%20head,you%20would%20like%20to%20purchase.">dropped 5% to $161.85 on May 19</a> after a three-day rally to $171.72, as profit-taking followed a burst of meme-coin activity and infrastructure news. While the pullback pressured price near key technical levels, underlying signals point to sustained ecosystem growth, developer momentum, and institutional engagement.
Solana&#8217;s first quarter app revenue surged 20% quarter-over-quarter to $1.2 billion, according to The Crypto Times. Pump.fun led with $257 million in revenue, highlighting Solana&#8217;s position as the hub for fast-moving meme coin launches. The stablecoin market cap on the chain soared 145% QoQ to $12.5 billion, even as DeFi TVL declined roughly 64%.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
DEX volumes jumped over 40% to $4.6 billion, and meme tokens like TrumpCoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) and MelaniaCoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MELANIA</a>) posted multi-day gains of 2x or more. On May 19, a whale wallet spent nearly $5.9 million on Solana meme coins, including WIF, Fartcoin, and BONK, per CryptoTimes.
Separately, DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) formed a validator partnership with BONK, co-running a node that bridges public markets with crypto-native assets.
Derivatives markets show positioning into strength. Open interest in SOL futures climbed 9% to $2.1 billion on Binance (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>), with a broader total of ~$5.55 billion across exchanges. Funding rates remain neutral to slightly negative, suggesting cautious bullishness without frothy leverage.
Daily active addresses rose 18% week-over-week to 1.2 million, and large wallet holders with 10,000+ SOL have increased by 1.5%, signaling accumulation rather than exit.
SOL is hovering around its 200-day moving average at $162. A confirmed break below $160 could open a path to the $145–$150 range, according to CoinGlass. Resistance sits near $180.45, with a potential upside target of $190 if sentiment rebounds.
Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) tight consolidation around $103,000 has redirected trader focus to higher-beta assets like SOL. This inter-asset flow continues to amplify price volatility across Solana-linked tokens.
Forward-looking catalysts include U.S. regulatory updates, staking reward changes, and broader institutional integrations. CoinCodex notes that a break above $190 could set up a retest of the $200 level last reached in Q1.
Despite the short-term pullback, Solana&#8217;s core metrics—rising app revenue, surging stablecoin use, dev growth, and enterprise adoption—suggest the dip is more consolidation than reversal. The fundamentals remain intact, and the bid from whales, builders, and institutions appears to be holding.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BTC

$MELANIA

$SOL

$TRUMP

DFDV

Solana Slides As Meme-Coin Rally Cools, Enterprise Engagement And Open Interest Stay Hot

Macquarie analyst Tim Nollen maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Outperform and raises the price target from $90 to $92.

Macquarie Maintains Outperform on Trade Desk, Raises Price Target to $92

Morgan Stanley analyst Nigel Dally maintains Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Equal-Weight and raises the price target from $108 to $117.

Morgan Stanley Maintains Equal-Weight on Prudential Financial, Raises Price Target to $117

Lianhe Sowell International Shares Halted On Circuit Breaker To The Downside, Stock Now Down -27.2%

<a href="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05192025_RANI_Vandermosten.pdf" title="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05192025_RANI_Vandermosten.pdf">https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05192025_RANI_Vandermosten.pdf</a>

RANI

Watching Rani Therapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation

Morgan Stanley analyst Bob Huang maintains Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) with a Underweight and raises the price target from $67 to $71.

Morgan Stanley Maintains Underweight on Principal Financial Group, Raises Price Target to $71

Morgan Stanley analyst Bob Huang maintains Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) with a Equal-Weight and raises the price target from $274 to $296.

Morgan Stanley Maintains Equal-Weight on Primerica, Raises Price Target to $296

ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-20. Here's what investors need to know before the announcement.
Analysts estimate that ProPhase Labs will report an earnings per share (EPS) of $-0.18. 
Investors in ProPhase Labs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.32 in the last quarter, leading to a 0.07% drop in the share price on the following day.
Here's a look at ProPhase Labs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-1.27</td>
<td>0.04</td>
<td>-0.24</td>
<td>-0.28</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.59</td>
<td>-0.35</td>
<td>-0.33</td>
<td>-0.07</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>-10.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747667013_0.png" alt="eps graph" />
<h3>Performance of ProPhase Labs Shares</h3>
Shares of ProPhase Labs were trading at $0.387 as of May 16. Over the last 52-week period, shares are down 92.95%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PRPH/earnings">To track all earnings releases for ProPhase Labs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PRPH

ProPhase Labs's Earnings Outlook

Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-20. Here's what investors need to know before the announcement.
Analysts estimate that Canaan will report an earnings per share (EPS) of $-0.15. 
Anticipation surrounds Canaan's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.19, leading to a 2.48% drop in the share price the following trading session.
Here's a look at Canaan's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.14</td>
<td>-0.15</td>
<td>-0.02</td>
<td>-0.36</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.33</td>
<td>-0.27</td>
<td>-0.15</td>
<td>-0.16</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>9.0%</td>
<td>4.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747667004_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Canaan were trading at $0.7933 as of May 16. Over the last 52-week period, shares are down 27.02%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/CAN/earnings">To track all earnings releases for Canaan visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Canaan

Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-20. Here's what investors need to know before the announcement.
Analysts estimate that Bioceres Crop Solutions will report an earnings per share (EPS) of $-0.10. 
The market awaits Bioceres Crop Solutions's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.09, which was followed by a 13.87% drop in the share price the next day.
Here's a look at Bioceres Crop Solutions's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.09</td>
<td>-0.01</td>
<td>0.24</td>
<td>0.170</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>-0.08</td>
<td>-0.03</td>
<td>0.139</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-14.000000000000002%</td>
<td>3.0%</td>
<td>-13.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747666993_0.png" alt="eps graph" />
<h3>Market Performance of Bioceres Crop Solutions's Stock</h3>
Shares of Bioceres Crop Solutions were trading at $4.65 as of May 16. Over the last 52-week period, shares are down 58.51%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analysts' Perspectives on Bioceres Crop Solutions</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Bioceres Crop Solutions.
Bioceres Crop Solutions has received a total of 1 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $7.0, the consensus suggests a potential 50.54% upside.
<h3>Analyzing Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Intrepid Potash, FMC and Mosaic, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Sell trajectory for Intrepid Potash, with an average 1-year price target of $19.5, suggesting a potential 319.35% upside.</li>
<li>Analysts currently favor an Outperform trajectory for FMC, with an average 1-year price target of $48.71, suggesting a potential 947.53% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Mosaic, with an average 1-year price target of $32.48, suggesting a potential 598.49% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for Intrepid Potash, FMC and Mosaic are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bioceres Crop Solutions</td>
<td>Outperform</td>
<td>-23.90%</td>
<td>$44.09M</td>
<td>0.05%</td>
</tr>
<tr>
<td>Intrepid Potash</td>
<td>Sell</td>
<td>23.30%</td>
<td>$14.60M</td>
<td>0.97%</td>
</tr>
<tr>
<td>FMC</td>
<td>Outperform</td>
<td>-13.79%</td>
<td>$316.70M</td>
<td>-0.35%</td>
</tr>
<tr>
<td>Mosaic</td>
<td>Neutral</td>
<td>-2.18%</td>
<td>$488.40M</td>
<td>2.05%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Bioceres Crop Solutions ranks at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity. The company's performance is below average compared to its peers in terms of revenue growth and gross profit, but it is performing better in terms of return on equity.
<h3>Get to Know Bioceres Crop Solutions Better</h3>
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
<h3>A Deep Dive into Bioceres Crop Solutions's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Bioceres Crop Solutions faced challenges, resulting in a decline of approximately -23.9% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Bioceres Crop Solutions's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.13%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.05%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Bioceres Crop Solutions's ROA excels beyond industry benchmarks, reaching 0.02%. This signifies efficient management of assets and strong financial health.
Debt Management: Bioceres Crop Solutions's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.92, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<a href="https://www.benzinga.com/quote/BIOX/earnings">To track all earnings releases for Bioceres Crop Solutions visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIOX

Bioceres Crop Solutions Earnings Preview

Arbe Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) is preparing to release its quarterly earnings on Tuesday, 2025-05-20. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Arbe Robotics to report an earnings per share (EPS) of $0.08.
Anticipation surrounds Arbe Robotics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.01, which was followed by a 3.7% drop in the share price the next day.
Here's a look at Arbe Robotics's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.10</td>
<td>-0.11</td>
<td>-0.17</td>
<td>-0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.11</td>
<td>-0.13</td>
<td>-0.09</td>
<td>-0.14</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-7.000000000000001%</td>
<td>-3.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747666978_0.png" alt="eps graph" />
<h3>Market Performance of Arbe Robotics's Stock</h3>
Shares of Arbe Robotics were trading at $1.77 as of May 16. Over the last 52-week period, shares are down 4.08%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ARBE/earnings">To track all earnings releases for Arbe Robotics visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBE

An Overview of Arbe Robotics's Earnings

Press Releases

Ryan Specialty Signs Definitive Agreement to Acquire Velocity Risk Underwriters

Ryan Specialty to Announce Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

Ryan Specialty Completes Acquisition of Velocity Risk Underwriters

Ryan Specialty Reports Fourth Quarter 2024 Results

Ryan Specialty to Announce First Quarter 2025 Financial Results on Thursday, May 1, 2025

Ryan Specialty Announces Time Change for First Quarter 2025 Conference Call

Ryan Specialty Signs Definitive Agreement To Acquire USQRisk Holdings

Ryan Specialty Reports First Quarter 2025 Results

Ryan Specialty Completes Acquisition of USQRisk Holdings

Velocity Announces Strategic Sale of Velocity Specialty Insurance Company; Oaktree to Fully Exit

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

AIFU

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Ryan Specialty Hldgs

Ryan Specialty Hldgs (RYAN) 옵션

Ryan Specialty Hldgs (NYSE:RYAN) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌